Firm News
Netlist Secures Landmark Agreement with Samsung
Agreement includes up to $898 million in patent licensing fees for Netlist over five years.
Read More
Firm News
Sterne Kessler and Thomson Reuters Partner to Create New AI Tool for Patent Litigation
Read More
Award
Sterne Kessler and Director Eldora Ellison Win Top Awards
2026 Life Sciences Americas Awards
Read More
Award
Sterne Kessler Named “Distinguished” Firm for IP Litigation and “Leader” in Generative AI Litigation
BTI Litigation Outlook 2027
Read MoreFeatured Experience
Life Sciences Resource Center
Practical guidance to help founders, inventors, in-house counsel, and investors build strong IP strategies. From early patent filing decisions and portfolio development to global protection, prosecution, and transaction readiness, gain the insights you need to make informed IP decisions at any stage.
Access the Resource Center
Artificial Intelligence
Companies across nearly every industry vertical are developing or utilizing AI and machine learning (ML) technologies to optimize operations, reduce costs, and gain a competitive advantage. Sterne Kessler helps clients develop comprehensive IP solutions that protect innovation, foster growth, and maximize value.
Explore AI Insights
PTAB Trials: IPRs, PGRs, DERs
Nationally recognized as the 2026 “PTAB Firm of the Year” by Managing Intellectual Property, Sterne Kessler’s PTAB trials team represents petitioners and patent owners in inter partes and post-grant review proceedings across a range of technologies. We bring deep experience and proven results to help clients navigate this evolving patent landscape.
Meet Our PTAB Team
Design Patents
For more than four decades, Sterne Kessler has been at the forefront of design patents, delivering successful outcomes for clients in securing and defending design rights. Our recognition from Managing IP as the inaugural “Design Patent Firm of the Year” reflects what our clients already know — design rights matter and experience matters even more.
Protect Product DesignsFeatured News
More News & Insights
Key Takeaways: Navigating Follow-On Patents in Bio-Pharma
Recent case law and evolving U.S. Patent and Trademark Office (USPTO) practices are raising the stakes for how follow-on patent portfolios are drafted, prosecuted, defended, and challenged. In…
Transformative Means More Than “Powered by AI”
Last week, the Third Circuit issued one of the first appellate rulings on copyright and AI training in Thomson Reuters v. ROSS Intelligence. The court held Westlaw’s headnotes…
Sterne Kessler and Directors Recognized in IAM and WTR’s Inaugural Copyright 1000
Washington, D.C. (October 1, 2026) – Sterne, Kessler, Goldstein & Fox and two directors were ranked in the inaugural edition of Intellectual Asset Management (IAM) and World Trademark…
How “Material Error” Has Become Key To Avoiding Discretionary Denial at the PTAB
Former associate, Tyler Drye, contributed to this article. Introduction Discretionary denial has long been one of the most important—and sometimes unpredictable—features of PTAB practice. Although the statutory bases…
Ninth Circuit Rejects DMCA Attribution Claims Against Generative AI Outputs
The DMCA may no longer provide a shortcut some copyright owners hoped for against generative AI outputs. The prospect of statutory damages, no fair-use fight, and no need…
Sterne Kessler Secures Patent Litigation Victory for Teva in Sleep Disorder Drug Dispute
Washington, D.C. (September 29, 2026) – Sterne, Kessler, Goldstein & Fox secured a favorable ruling on behalf of Teva Pharmaceuticals in a patent infringement case brought by Vanda…
Your innovations are worth the best protection
Expertise
Sterne Kessler is a full-service IP firm that delivers innovative solutions tailored to your business and industry.